TRUST CO OF VERMONT - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 201 filers reported holding HALOZYME THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is 0.47 and the average weighting 0.3%.

Quarter-by-quarter ownership
TRUST CO OF VERMONT ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$7,640
+5.9%
2000.0%0.00%
Q2 2023$7,214
-5.6%
2000.0%0.00%
-100.0%
Q1 2023$7,638
-32.9%
2000.0%0.00%0.0%
Q4 2022$11,380
+42.2%
2000.0%0.00%0.0%
Q3 2022$8,000
-11.1%
2000.0%0.00%0.0%
Q2 2022$9,000
+12.5%
2000.0%0.00%0.0%
Q4 2021$8,000
-11.1%
2000.0%0.00%0.0%
Q2 2021$9,000
+12.5%
2000.0%0.00%0.0%
Q1 2021$8,000
-11.1%
2000.0%0.00%0.0%
Q4 2020$9,000
+80.0%
2000.0%0.00%
Q3 2020$5,0000.0%2000.0%0.00%
Q2 2020$5,000
+25.0%
2000.0%0.00%
Q1 2020$4,0000.0%2000.0%0.00%
Q4 2019$4,000
+33.3%
2000.0%0.00%
Q3 2019$3,0000.0%2000.0%0.00%
Q2 2019$3,0000.0%2000.0%0.00%
Q1 2019$3,0000.0%2000.0%0.00%
Q4 2018$3,000
-25.0%
2000.0%0.00%
Q3 2018$4,000
+33.3%
2000.0%0.00%
Q2 2018$3,000
-25.0%
2000.0%0.00%
Q1 2018$4,0000.0%2000.0%0.00%
Q4 2017$4,0002000.00%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q4 2017
NameSharesValueWeighting ↓
Third Security, LLC 1,129,551$47,091,0006.38%
First Light Asset Management, LLC 2,011,350$83,853,0005.56%
TRAN CAPITAL MANAGEMENT, L.P. 1,353,208$56,415,0005.03%
SNYDER CAPITAL MANAGEMENT L P 2,920,860$121,771,0003.50%
DOHENY ASSET MANAGEMENT /CA 120,028$5,004,0003.39%
SILVERARC CAPITAL MANAGEMENT, LLC 104,945$4,375,0002.39%
Redwood Investments, LLC 542,764$22,628,0001.99%
Kent Lake Capital LLC 85,000$3,544,0001.44%
Lisanti Capital Growth, LLC 263,460$10,984,0001.41%
Bellevue Group AG 3,011,966$125,569,0001.33%
View complete list of HALOZYME THERAPEUTICS INC shareholders